These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29308317)

  • 1. High numbers of PDCD1 (PD-1)-positive T cells and
    Janikovits J; Müller M; Krzykalla J; Körner S; Echterdiek F; Lahrmann B; Grabe N; Schneider M; Benner A; Doeberitz MVK; Kloor M
    Oncoimmunology; 2018; 7(2):e1390640. PubMed ID: 29308317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low density of FOXP3-positive T cells in normal colonic mucosa is related to the presence of beta2-microglobulin mutations in Lynch syndrome-associated colorectal cancer.
    Echterdiek F; Janikovits J; Staffa L; Müller M; Lahrmann B; Frühschütz M; Hartog B; Nelius N; Benner A; Tariverdian M; von Knebel Doeberitz M; Grabe N; Kloor M
    Oncoimmunology; 2016 Feb; 5(2):e1075692. PubMed ID: 27057447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lynch syndrome-associated epithelial ovarian cancer and its immunological profile.
    Rasmussen M; Lim K; Rambech E; Andersen MH; Svane IM; Andersen O; Jensen LH; Nilbert M; Therkildsen C
    Gynecol Oncol; 2021 Sep; 162(3):686-693. PubMed ID: 34275654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes.
    Michel S; Linnebacher M; Alcaniz J; Voss M; Wagner R; Dippold W; Becker C; von Knebel Doeberitz M; Ferrone S; Kloor M
    Int J Cancer; 2010 Aug; 127(4):889-98. PubMed ID: 20013806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex pattern of immune evasion in MSI colorectal cancer.
    Ozcan M; Janikovits J; von Knebel Doeberitz M; Kloor M
    Oncoimmunology; 2018; 7(7):e1445453. PubMed ID: 29900056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined prognostic value of CD274 (PD-L1)/PDCDI (PD-1) expression and immune cell infiltration in colorectal cancer as per mismatch repair status.
    Ahtiainen M; Wirta EV; Kuopio T; Seppälä T; Rantala J; Mecklin JP; Böhm J
    Mod Pathol; 2019 Jun; 32(6):866-883. PubMed ID: 30723299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful immune checkpoint blockade in a patient with advanced stage microsatellite-unstable biliary tract cancer.
    Czink E; Kloor M; Goeppert B; Fröhling S; Uhrig S; Weber TF; Meinel J; Sutter C; Weiss KH; Schirmacher P; Doeberitz MVK; Jäger D; Springfeld C
    Cold Spring Harb Mol Case Stud; 2017 Sep; 3(5):. PubMed ID: 28619747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Majority of
    Middha S; Yaeger R; Shia J; Stadler ZK; King S; Guercio S; Paroder V; Bates DDB; Rana S; Diaz LA; Saltz L; Segal N; Ladanyi M; Zehir A; Hechtman JF
    JCO Precis Oncol; 2019; 3():. PubMed ID: 31008436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. γδ T cells are effectors of immunotherapy in cancers with HLA class I defects.
    de Vries NL; van de Haar J; Veninga V; Chalabi M; Ijsselsteijn ME; van der Ploeg M; van den Bulk J; Ruano D; van den Berg JG; Haanen JB; Zeverijn LJ; Geurts BS; de Wit GF; Battaglia TW; Gelderblom H; Verheul HMW; Schumacher TN; Wessels LFA; Koning F; de Miranda NFCC; Voest EE
    Nature; 2023 Jan; 613(7945):743-750. PubMed ID: 36631610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer.
    Surmann EM; Voigt AY; Michel S; Bauer K; Reuschenbach M; Ferrone S; von Knebel Doeberitz M; Kloor M
    Cancer Immunol Immunother; 2015 Mar; 64(3):357-66. PubMed ID: 25445815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B2M and JAK1/2-mutated MSI-H Colorectal Carcinomas Can Benefit From Anti-PD-1 Therapy.
    Zhang C; Li D; Xiao B; Zhou C; Jiang W; Tang J; Li Y; Zhang R; Han K; Hou Z; Zhang L; Sui Q; Liao L; Pan Z; Zhang X; Ding P
    J Immunother; 2022 May; 45(4):187-193. PubMed ID: 35343934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of β-2-microglobulin expression in colorectal cancers stratified by mismatch repair status.
    Koelzer VH; Baker K; Kassahn D; Baumhoer D; Zlobec I
    J Clin Pathol; 2012 Nov; 65(11):996-1002. PubMed ID: 22859396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated neoantigen levels in tumors with somatic mutations in the HLA-A, HLA-B, HLA-C and B2M genes.
    Castro A; Ozturk K; Pyke RM; Xian S; Zanetti M; Carter H
    BMC Med Genomics; 2019 Jul; 12(Suppl 6):107. PubMed ID: 31345234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial Cancer.
    Ramchander NC; Ryan NAJ; Walker TDJ; Harries L; Bolton J; Bosse T; Evans DG; Crosbie EJ
    Front Immunol; 2019; 10():3023. PubMed ID: 31998307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution.
    Ballhausen A; Przybilla MJ; Jendrusch M; Haupt S; Pfaffendorf E; Seidler F; Witt J; Hernandez Sanchez A; Urban K; Draxlbauer M; Krausert S; Ahadova A; Kalteis MS; Pfuderer PL; Heid D; Stichel D; Gebert J; Bonsack M; Schott S; Bläker H; Seppälä T; Mecklin JP; Ten Broeke S; Nielsen M; Heuveline V; Krzykalla J; Benner A; Riemer AB; von Knebel Doeberitz M; Kloor M
    Nat Commun; 2020 Sep; 11(1):4740. PubMed ID: 32958755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confirmation that somatic mutations of beta-2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial.
    Barrow P; Richman SD; Wallace AJ; Handley K; Hutchins GGA; Kerr D; Magill L; Evans DG; Gray R; Quirke P; Hill J
    Histopathology; 2019 Aug; 75(2):236-246. PubMed ID: 31062389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoprofiles of colorectal cancer from Lynch syndrome.
    Walkowska J; Kallemose T; Jönsson G; Jönsson M; Andersen O; Andersen MH; Svane IM; Langkilde A; Nilbert M; Therkildsen C
    Oncoimmunology; 2019; 8(1):e1515612. PubMed ID: 30546958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mismatch repair deficiency is associated with MSI phenotype, increased tumor-infiltrating lymphocytes and PD-L1 expression in immune cells in ovarian cancer.
    Xiao X; Dong D; He W; Song L; Wang Q; Yue J; Xie L
    Gynecol Oncol; 2018 Apr; 149(1):146-154. PubMed ID: 29496294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β2-microglobulin expression is associated with aggressive histology, activated tumor immune milieu, and outcome in colon carcinoma.
    Lee SH; Pankaj A; Rickelt S; Ting D; Ferrone C; Patil DT; Yilmaz O; Berger D; Deshpande V; Yilmaz O
    Am J Clin Pathol; 2024 Nov; 162(5):500-508. PubMed ID: 38869306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why is immunotherapy effective (or not) in patients with MSI/MMRD tumors?
    Nebot-Bral L; Coutzac C; Kannouche PL; Chaput N
    Bull Cancer; 2019 Feb; 106(2):105-113. PubMed ID: 30342749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.